medigraphic.com

2010, Number 1

Next >>

Rev Med Inst Mex Seguro Soc 2010; 48 (1)

Bone tissue as an endocrine gland

Zárate A, Basurto L, Saucedo R

Language: Spanish
References: 14
Page: 1-5
PDF size: 43.54 Kb.


Text Extraction

Bone tissue was essentially considered as a mechanical structure; however is now well known that is the site of permanent bone remodelation. In addition, bone functions as an endocrine gland producing osteocalcin, which in turn interacts with other tissues, such as fat, pancreas and gastrointestinal tract. As a consequence, osteocalcin intervenes into glucose metabolism, peripheral insulin sensitivity and inflammatory process. In sum, bone may be accepted as an endocrine gland.


REFERENCES

  1. Rizzoli R. Osteoporosis: non-hormonal treatment. Climateric 2007;10(Suppl 2):74-78.

  2. Zárate TA, Basurto AL, Hernández VM, Saucedo GR. Conducta terapéutica actual para la osteoporosis en la mujer y en el hombre. Med Int Mex 2007;23(3):210-216.

  3. Albright F, Smith PH, Richardson AM. Postmenopausal osteoporosis: its clinical features. JAMA 1941;116(22):2465-2474.

  4. Reifenstein EC, Albright F. The metabolic effects of steroid hormones in osteoporosis. J Clin Invest 1947;26(1):24-56.

  5. Bezooijen RL, Roelen BAJ, Visser A, van der Wee Pals L, de Wilt E, Karperien M, et al. Sclerostin is an osteocyte-expressed negative regulator of bone formation, but not a classical bmp antagonist. JEM 2004;199(6):805-814.

  6. Yadav VK, Ryu JH, Suda N. Tanaka KF, Gingrich JA, Schütz G, et al. Lrp5 controls bone formation by inhibiting serotonin synthesis in the duodenum. Cell 2008;135(5):825-837.

  7. Boyle WJ, Simonet WS, Lacey DL. Osteoclast differentiation and activation. Nature 2003;423 (6937):337-342.

  8. Pittas AG, Harris SS, Eliades M, Starck P, Dawson- Hughes B. Association between serum osteocalcin and markers of metabolic phenotype. J Clin Endocrinol Metab 2009;94(3):827-832.

  9. Kanazawa I, Yamaguchi T, Yamamoto M, Yamauchi M, Kurioka S, Yano S, et al. Serum osteocalcin level is associated with glucose metabolism and atherosclerosis parameters in type 2 diabetes mellitus. J Clin Endocrinol Metab 2009;94(1):45-49.

  10. Buday B, Kulcsár E, Literáti NB, Horváth T, Vitai M, Vecsei I, et al. The role of osteocalcin in the connection of bone and glucose metabolism in humans. Orv Hetil 2008;149(52):2453-2461.

  11. Basurto L, Zárate A, Córdova N, Saucedo R, Galván R, Campos S, et al. Efficacy of strontium ranelate for the mineralization of bone in postmenopausal women. Ginecol Obstet Mex 2009;77(5):227-230.

  12. Rosen CJ. Serotonin rising-the bone, brain, bowel connection. New Engl J Med 2009;360(19):957-959.

  13. Sowers MF, Scholl T, Grewal J, Chen X, Jannausch M. IGF-I, osteocalcin and bone change in pregnant normotensive and pre-eclamptic women. J Clin Encocrinol Metab 2001;86(12):5898-5903.

  14. Zárate A, Hernández M. Fuller Albright el “Picasso de la endocrinología” y “profeta de la anticoncepción hormonal”. Acta Med 2005;3(3):205-206.




2020     |     www.medigraphic.com